BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 30793177)

  • 1. Vitamin D for the Immune System in Cystic Fibrosis (DISC): a double-blind, multicenter, randomized, placebo-controlled clinical trial.
    Tangpricha V; Lukemire J; Chen Y; Binongo JNG; Judd SE; Michalski ES; Lee MJ; Walker S; Ziegler TR; Tirouvanziam R; Zughaier SM; Chesdachai S; Hermes WA; Chmiel JF; Grossmann RE; Gaggar A; Joseph PM; Alvarez JA
    Am J Clin Nutr; 2019 Mar; 109(3):544-553. PubMed ID: 30793177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC) trial: Rationale and design of a multi-center, double-blind, placebo-controlled trial of high dose bolus administration of vitamin D3 during acute pulmonary exacerbation of cystic fibrosis.
    Tangpricha V; Smith EM; Binongo J; Judd SE; Ziegler TR; Walker S; Tirouvanziam R; Zughaier SM; Lee MJ; Chesdachai S; Hermes WA; Chmiel JF; Gaggar A; Grossmann RE; Joseph PM; Alvarez JA
    Contemp Clin Trials Commun; 2017 Jun; 6():39-45. PubMed ID: 28508087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective, Randomized, Double-Blind, Parallel-Group, Comparative Effectiveness Clinical Trial Comparing a Powder Vehicle Compound of Vitamin D With an Oil Vehicle Compound in Adults With Cystic Fibrosis.
    Hermes WA; Alvarez JA; Lee MJ; Chesdachai S; Lodin D; Horst R; Tangpricha V
    JPEN J Parenter Enteral Nutr; 2017 Aug; 41(6):952-958. PubMed ID: 26903303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of vitamin D supplementation on markers of inflammation in adults with cystic fibrosis hospitalized for a pulmonary exacerbation.
    Grossmann RE; Zughaier SM; Liu S; Lyles RH; Tangpricha V
    Eur J Clin Nutr; 2012 Sep; 66(9):1072-4. PubMed ID: 22805498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D for glycemic control following an acute pulmonary exacerbation: A secondary analysis of a multicenter, double-blind, randomized, placebo-controlled trial in adults with cystic fibrosis.
    Sivapiromrat AK; Hunt WR; Alvarez JA; Ziegler TR; Tangpricha V
    medRxiv; 2024 Mar; ():. PubMed ID: 38343807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D supplementation for cystic fibrosis.
    Ferguson JH; Chang AB
    Cochrane Database Syst Rev; 2014 May; (5):CD007298. PubMed ID: 24823922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial.
    Lehouck A; Mathieu C; Carremans C; Baeke F; Verhaegen J; Van Eldere J; Decallonne B; Bouillon R; Decramer M; Janssens W
    Ann Intern Med; 2012 Jan; 156(2):105-14. PubMed ID: 22250141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma metabolomics in adults with cystic fibrosis during a pulmonary exacerbation: A pilot randomized study of high-dose vitamin D
    Alvarez JA; Chong EY; Walker DI; Chandler JD; Michalski ES; Grossmann RE; Uppal K; Li S; Frediani JK; Tirouvanziam R; Tran VT; Tangpricha V; Jones DP; Ziegler TR
    Metabolism; 2017 May; 70():31-41. PubMed ID: 28403943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Vitamin D3 Supplementation on Severe Asthma Exacerbations in Children With Asthma and Low Vitamin D Levels: The VDKA Randomized Clinical Trial.
    Forno E; Bacharier LB; Phipatanakul W; Guilbert TW; Cabana MD; Ross K; Covar R; Gern JE; Rosser FJ; Blatter J; Durrani S; Han YY; Wisniewski SR; Celedón JC
    JAMA; 2020 Aug; 324(8):752-760. PubMed ID: 32840597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical impact of vitamin D treatment in cystic fibrosis: a pilot randomized, controlled trial.
    Pincikova T; Paquin-Proulx D; Sandberg JK; Flodström-Tullberg M; Hjelte L
    Eur J Clin Nutr; 2017 Feb; 71(2):203-205. PubMed ID: 27966575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors Contributing to Vitamin D Status at Hospital Admission for Pulmonary Exacerbation in Adults With Cystic Fibrosis.
    Bhimavarapu A; Deng Q; Bean M; Lee N; Ziegler TR; Alvarez J; Tangpricha V
    Am J Med Sci; 2021 Jan; 361(1):75-82. PubMed ID: 32988598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose vitamin D3 in adults with pulmonary tuberculosis: a double-blind randomized controlled trial.
    Tukvadze N; Sanikidze E; Kipiani M; Hebbar G; Easley KA; Shenvi N; Kempker RR; Frediani JK; Mirtskhulava V; Alvarez JA; Lomtadze N; Vashakidze L; Hao L; Del Rio C; Tangpricha V; Blumberg HM; Ziegler TR
    Am J Clin Nutr; 2015 Nov; 102(5):1059-69. PubMed ID: 26399865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EMPIRE-CF: A phase II randomized placebo-controlled trial of once-daily, oral acebilustat in adult patients with cystic fibrosis - Study design and patient demographics.
    Elborn JS; Ahuja S; Springman E; Mershon J; Grosswald R; Rowe SM
    Contemp Clin Trials; 2018 Sep; 72():86-94. PubMed ID: 30056216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial.
    Lechtzin N; West N; Allgood S; Wilhelm E; Khan U; Mayer-Hamblett N; Aitken ML; Ramsey BW; Boyle MP; Mogayzel PJ; Goss CH
    Contemp Clin Trials; 2013 Nov; 36(2):460-9. PubMed ID: 24055998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D supplementation for cystic fibrosis.
    Ferguson JH; Chang AB
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007298. PubMed ID: 19821402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D supplementation in chronic obstructive pulmonary disease patients with low serum vitamin D: a randomized controlled trial.
    Rafiq R; Aleva FE; Schrumpf JA; Daniels JM; Bet PM; Boersma WG; Bresser P; Spanbroek M; Lips P; van den Broek TJ; Keijser BJF; van der Ven AJAM; Hiemstra PS; den Heijer M; de Jongh RT;
    Am J Clin Nutr; 2022 Aug; 116(2):491-499. PubMed ID: 35383823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial.
    Martineau AR; James WY; Hooper RL; Barnes NC; Jolliffe DA; Greiller CL; Islam K; McLaughlin D; Bhowmik A; Timms PM; Rajakulasingam RK; Rowe M; Venton TR; Choudhury AB; Simcock DE; Wilks M; Degun A; Sadique Z; Monteiro WR; Corrigan CJ; Hawrylowicz CM; Griffiths CJ
    Lancet Respir Med; 2015 Feb; 3(2):120-130. PubMed ID: 25476069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D supplementation for cystic fibrosis.
    Ferguson JH; Chang AB
    Cochrane Database Syst Rev; 2012 Apr; (4):CD007298. PubMed ID: 22513949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D intake, serum 25-hydroxy vitamin D and pulmonary function in paediatric patients with cystic fibrosis: a longitudinal approach.
    Timmers NKLM; Stellato RK; van der Ent CK; Houwen RHJ; Woestenenk JW
    Br J Nutr; 2019 Jan; 121(2):195-201. PubMed ID: 30442206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of vitamin D
    Sudfeld CR; Mugusi F; Muhihi A; Aboud S; Nagu TJ; Ulenga N; Hong B; Wang M; Fawzi WW
    Lancet HIV; 2020 Jul; 7(7):e463-e471. PubMed ID: 32621874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.